| Detected | Trial | Change |
|---|---|---|
| 2026-05-23 | NCT05668741 A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF) |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-23 | NCT05668741 A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF) |
Enrollment reduced: 39 -> 26 participants |
| 2026-05-23 | NCT05668741 A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF) |
Trial sites reduced: 43 -> 26 locations |
| 2026-05-23 | NCT05668741 A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF) |
date change Primary completion moved earlier: 2026-12-23 -> 2026-04-21 |
| 2026-05-23 | NCT05668741 A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF) |
date change Completion moved earlier: 2027-05-12 -> 2026-09-09 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT05331183 | Study to Evaluate Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) Long-term Safety and… | Cystic Fibrosis | Active, Not Recruiting |
| NCT06460506 | Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis… | Cystic Fibrosis | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT05668741 | A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF) | Cystic Fibrosis | Active, Not Recruiting |